“Desafortunadamente, as a result of this abrupt decision made by the federal government
, all monoclonal antibody state sites will be closed until further notice
,” el Departamento de Salud de Florida dijo en un comunicado
Some people who’ve received monoclonal antibody treatment reported rashes
, nausea and dizziness after treatment
, according to the National Institutes of Health
. A small percentage of patients had severe allergic reactions
The FDA’s announcement came after senior health officials in the Biden administration called the offices of governors and state health officials a principios de este mes
, urging them against using these treatments with Omicron
, a source familiar with the calls said
DeSantis has made monoclonal antibodies a cornerstone of his response to surges of coronavirus cases, often pushing the treatment more vigorously than vaccines.
El verano pasado, he introduced new clinics where individuals could receive the treatment at the onset of symptoms or exposure to someone with Covid-19.
A principios de este mes, en medio de un record-breaking surge of Covid-19 cases
, DeSantis assailed the Biden administration for pausing shipments of the monoclonal antibodies
, and has pushed for the treatment to remain widely available
En enero 7, DeSantis said he’d secured
15,000 doses of Regeneron’s antibody treatment for the state
, despite the pharmaceutical company saying in December its REGEN-COV antibodies
“have diminished potency against Omicron.
DeSantis slammed the FDA’s announcement in a estado de cuenta el lunes
, saying the Biden administration
“has forced trained medical professionals to choose between treating their patients or breaking the law.
GlaxoSmithKline’s monoclonal antibody, sotrovimab, is the only version of the treatment that appears to work against Omicron, the FDA said last month.
En el momento, the Assistant Secretary for Preparedness and Response and the FDA paused allocations of the Eli Lilly and Regeneron monoclonal antibodies, but said 300,000 additional doses of sotrovimab would be made available in January.